August J. Troendle - Aug 5, 2024 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol: MEDP
Transactions as of: Aug 5, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/7/2024, 04:14 PM
Previous filing: May 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MEDP	Common Stock						655K	Aug 5, 2024	Direct
holding	MEDP	Common Stock						4.73M	Aug 5, 2024	By Medpace Investors, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEDP	Employee Stock Option (Right to Buy)	Award	$0	+50K		$0.00	50K	Aug 5, 2024	Common Stock	50K	$377.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2	The option vests immediately upon issuance.

Content

The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

The option vests immediately upon issuance.